Centaurus Financial’s Medifast MED Stock Holding History

Centaurus Financial’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-646	Closed	-$103K	–	1425
2018 Q2	$103K	Buy	+646	New	+$82.6K	0.01%	702

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Centaurus Financial's MED Position: Q3 2018 in Review

Centaurus Financial sold out of Medifast (MED) in Q3 2018, closing a stake of 646 shares — an estimated $103K sold.

Centaurus Financial first reported a position in MED in Q2 2018 and held it in 1 quarter. The position peaked at $103K in Q2 2018. 266 funds tracked by Wall St. Rank hold MED as of Q3 2018.

Centaurus Financial reported no remaining Medifast position as of Q3 2018 after selling out during the quarter.
Centaurus Financial sold 646 Medifast shares in Q3 2018, an estimated $103K.
Centaurus Financial first reported a position in Medifast in Q2 2018 and held it in 1 quarter.
Centaurus Financial's Medifast position peaked at $103K in Q2 2018.
266 funds tracked by Wall St. Rank held Medifast as of Q3 2018.

Based on Centaurus Financial's 13F filing for Q3 2018, filed 5 Nov 2018.